Strategic Partnerships Opportunity to expand collaboration with pharmaceutical and analytics partners shown by past and ongoing collaborations with GenomOncology, API Innovation Center, Cortex, and Continuity Pharma. Potential to position Glioblastoma Foundation as a conduit for co-developed therapies, manufacturing partnerships, and patient access programs.

Cost Reduction Recent initiatives focus on domestic, high-quality lomustine production to reduce patient costs and secure supply. This creates a sales opening for suppliers of API development, contract manufacturing, regulatory support, and supply chain resilience services.

Awareness to Action Active patient and public awareness campaigns coupled with research funding create demand for patient engagement tools, educational content platforms, and event-based donor campaigns. Potential for digital marketing services, content management, and donor CRM integration.

Tech Enablement Tech stack includes Shopify, WordPress-like tools, and server infrastructure, signaling openness to a broader digital commerce and site optimization partnership. Potential to offer e-commerce enhancements, analytics, security hardening, and CMS optimization for fundraising and advocacy.

Funding Readiness Revenue under $1M with a strong focus on partnerships and product access programs suggests opportunities for grant management, donor platform integration, and financial planning services to scale fundraising and sustain research initiatives.